Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice

Journal of Hepatology

Volumn 24, Issue 2, 1996, Pages 200-208

  Lettéron, Philippe ^a   Fromenty, Bernard ^a   Terris, Benoît ^a   Degott, Claude ^a   Pessayre, Dominique ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Drugs; Ethanol; Lipid peroxidation; Steatohepatitis; Steatosis

Indexed keywords

ALCOHOL; AMINEPTINE; AMIODARONE; CHLORTETRACYCLINE; DEMECLOCYCLINE; DEXAMETHASONE; DOXYCYCLINE; ETHIONINE; PIRPROFEN; TETRACYCLINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0342716457     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80030-4     Document Type: Article

References (50)

1. Suematsu T, Matsumara T, Sato N, Miyamo T, Ooka T, Kamuda T, Abe H. Lipid peroxidation in alcoholic liver disease in humans. Alcohol Clin Exp Res 1981; 5: 427-30.
2. Shaw S, Rubin KP, Lieber CS. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease. Evidence of lipid peroxidation. Dig Dis Sci 1983; 28: 585-9.
3. Tanner AR, Bantock I, Himks L, Lloyd B, Turner NR, Wright R. Depressed selenium and vitamin E levels in an alcoholic population. Possible relationship to hepatic injury through increased lipid peroxidation. Dig Dis Sci 1986; 31: 1307-12.
4. Girre C, Hispard E, Therond P, Guedj S, Bourdon R, Dally S. Effect of abstinence from alcohol on the depression of glutathione peroxidase activity and selenium and vitamin E levels in chronic alcoholic patients. Alcohol Clin Exp Res 1990; 14: 909-12.
5. Situnayake RD, Crump BJ, Thurnham DI, Davies JA, Gearty J, Davis M. Lipid peroxidation and hepatic antioxidants in alcoholic liver disease. Gut 1990; 31: 1311-7.
6. Van Gossum A, Decuyper J. Breath alkanes as an index of lipid peroxidation. Eur Respir J 1989; 2: 787-91.
7. Lettéron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Degott C, Benhamou JP, Pessayre D. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol abusers. Gut 1993; 34: 409-14.
8. Lieber CS. Biochemical and molecular basis of alcoholic-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639-50.
9. Zimmermann HJ. Hepatotoxicity. The Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton Century Crofts, 1978.
10. Pessayre D, Bichara M, Feldmann G, Degott C, Potet F, Benhamou JP. Perhexiline maleate-induced cirrhosis. Gastroenterology 1979; 76: 170-7.
11. Bray GA, Barry RE, Benfield JR, Castelnuovo-Tedesco P, Drenick EJ, Passaro E. Intestinal bypass operation as a treatment for obesity. Ann Intern Med 1976; 85: 97-109.
12. McGill DB, Humpherys SR, Archie H, Baggenstoss AH, Dickson ER. Cirrhosis and death after jejunoileal shunt. Gastroenterology 1972; 63: 872-7.
13. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
14. Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980; 78: 535-41.
15. Le Dinh T, Fréneaux E, Labbe G, Lettéron P, Degott C, Genève J, Berson A, Pessayre D. Amineptine, a tricyclic antidepressant, inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1988; 247: 745-50.
16. Fromenty B, Fisch C, Labbe G, Degott C, Deschamps D, Berson A, Lettéron P, Pessayre D. Amiodarone inhibits the mitochondrial β-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1990; 255: 1371-6.
17. Fromenty B, Fisch C, Berson A, Lettéron P, Larrey D, Pessayre D. Dual effect of amiodarone on mitochondrial respiration. Initial protonophoric uncoupling effect followed by inhibition of the respiratory chain at the levels of complex I and complex II. J Pharmacol Exp Ther 1990; 255: 1377-84.
18. Labbe G, Fromenty B, Fréneaux E, Morzelle V, Lettéron P, Berson A, Pessayre D. Effects of various tetracycline derivatives on in vitro and in vivo β-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 1991; 41: 638-41.
19. Fréneaux E, Labbe G, Lettéron P, Le Dinh T, Degott C, Genève J, Larrey D, Pessayre D. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology 1988; 8: 1056-62.
20. Genève J, Hayat-Bonan B, Labbe G, Degott C, Lettéron P, Fréneaux E, Le Dinh T, Pessayre D. Inhibition of mitochondrial β-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal antiinflammatory drug. J Pharmacol Exp Ther 1987; 242: 1133-7.
21. Kesterson JW, Granneman GR, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 1984; 4: 1143-52.
22. Farrell G. Drug-induced Liver Disease, London: Churchill-Livingstone, 1994.
23. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
24. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-7.
25. Lettéron P, Labbe G, Degott C, Berson A, Fromenty B, Delaforge M, Pessayre D. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochem Pharmacol 1990; 39: 2027-34.
26. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
27. Lundquist F. The determination of ethyl alcohol in blood and tissues. In: Glick D, ed. Methods of Biochemical Analysis, New York: Interscience, 1957; 217-51.
28. Ellman GL. Tissue sulfhydryls groups. Arch Biochem Biophys 1959; 82: 70-7.
29. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Rad Biol Med 1991; 11: 81-128.
30. Bellringer ME, Rahman K, Coleman R. Sodium valproate inhibits movement of secretory vesicles in rat hepatocytes. Biochem J 1988; 249: 513-9.
31. Breen KJ, Schenker S, Heimberg M. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex. Gastroenterology 1975; 69: 714-23.
32. Albano E, Tomasi A, Goria-Gatti L, Dianzani MU. Spin trapping of free radical species produced during the microsomal metabolism of ethanol. Chem Biol Interact 1988; 65: 223-34.
33. Reinke LA, Lai EK, Dubose CM, McCay PB. Reactive free radical generation in vivo in heart and liver of ethanol-fed rats: correlation with radical formation in vitro. Proc Natl Acad Sci USA 1987; 84: 9223-7.
34. Knecht KT, Bradford BU, Mason RP, Thurman RG. In vivo formation of a free radical metabolite of ethanol. Mol Pharmacol 1990; 38: 26-30.
35. Sultatos LG. Effects of acute ethanol administration on the hepatic xanthine dehydrogenase/oxidase system in the rat. J Pharmacol Exp Ther 1988; 246: 946-9.
36. Shaw S, Jayatilleke E. The role of aldehyde oxidase in ethanol-induced hepatic lipid peroxidation in the rat. Biochem J 1990; 268: 579-83.
37. Biemond P, Swaak JG, Beindorf CM, Koster JF. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin by xanthine oxidase. Biochem J 1986; 239: 169-73.
38. Kukielka E, Cederbaum AI. NADH-dependent microsomal interaction with ferric complexes and production of reactive oxygen intermediates. Arch Biochem Biophys 1989; 275: 540-50.
39. Devi BG, Henderson GI, Frosto TA, Schenker S. Effect of ethanol on rat fetal hepatocytes: studies on cell replication, lipid peroxidation and glutathione. Hepatology 1993; 18: 648-59.
40. Lamb RG, Koch JC, Snyder JW, Huband SM, Bush SR. An in vitro model of ethanol-dependent liver cell injury. Hepatology 1994; 19: 174-82.
41. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol 1993; 10: 465-7.
42. Recknagel RO, Glende EA, Dolack JA, Waller RL. Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 1989; 43: 139-54.
43. Tsukamato H, Kim CW, Luo ZZ, Home W, Su LC, Brittenham G. Role of lipid peroxidation in in vivo and in vitro models of liver fibrogenesis. Gastroenterology 1993; 104: A1012.
44. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen α1 (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis? Hepatology 1994; 19: 1262-71.
45. Curzio M, Esterbauer H, Dianzani MU. Chemotactic activity of hydroxyalkenals on rat neutrophils. Int J Tissue React 1985; 7: 137-42.
46. Pessayre D. Toxic and immune mechanisms leading to acute and subacute drug-induced liver injury. In: Miguet JP, Dhumeaux D, eds. Progress in Hepatology 93. Paris: John Libbey Eurotext, 1993; 23-39.
47. Katsuma Y, Swierenga SHH, Khettry U, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology 1987; 6: 1215-23.
48. Zatloukal K, Böck G, Rainer I, Denk H, Weber H. High molecular weight components are main constituents of Mallory bodies isolated with a fluorescence activated cell sorter. Lab Invest 1991; 64: 200-6.
49. Cadrin M, Marceau N, French SW. Cytokeratin of apparent high molecular weight in livers from griseofulvin-fed mice. J Hepatol 1992; 14: 226-31.
50. Deschamps D, de Beco V, Fisch C, Fromenty B, Guillouzo A, Pessayre D. Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions. Hepatology 1994; 4: 948-61.